WES data generated from a wide cohort of COVID-19 Italian patients revealed a statistically significant (P < 0,029) higher allelic heterogeneity for ACE2 in controls compared with patients with a higher chance to find at least one ACE2 variant in the cohort of controls compared with the cohort of patients. The gene discussed is ACE2; the disease is COVID-19.